LCTX SBC to Revenue

Lineage Cell Therapeutics, Inc. Common Stock · SBC to Revenue

LCTX logo

LCTX SBC to Revenue

Current (TTM)38.75%
LCTX TTM SBC/Revenue (38.75% → 38.75%)
More history is needed to export this chart.

LCTX sbc to revenue history

Published TTM snapshot. The date records when this current TTM value was retrieved.

Lineage Cell Therapeutics, Inc. Common Stock SBC to Revenue — Published TTM snapshot
RetrievedSBC to Revenue
38.7526%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.